In re Upjohn Co. Antibiotic Cleocin Products Liability Litigation

81 F.R.D. 482, 27 Fed. R. Serv. 2d 389, 1979 U.S. Dist. LEXIS 14991
CourtDistrict Court, E.D. Michigan
DecidedJanuary 18, 1979
DocketMDL No. 343
StatusPublished
Cited by31 cases

This text of 81 F.R.D. 482 (In re Upjohn Co. Antibiotic Cleocin Products Liability Litigation) is published on Counsel Stack Legal Research, covering District Court, E.D. Michigan primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Upjohn Co. Antibiotic Cleocin Products Liability Litigation, 81 F.R.D. 482, 27 Fed. R. Serv. 2d 389, 1979 U.S. Dist. LEXIS 14991 (E.D. Mich. 1979).

Opinion

OPINION AND ORDER GRANTING PLAINTIFFS’ MOTION TO VACATE PROTECTIVE ORDER AND DENYING DEFENDANT’S MOTION FOR PROTECTIVE ORDER

CORNELIA G. KENNEDY, Chief Judge.

Plaintiffs filed a motion to vacate a protective order entered by the District Court for the Eastern District of Louisiana in Barry G. Escher v. Aetna Casualty & Surety Co., now part of M.D.L. No. 343. Defendant has acknowledged that insofar as that information has been released in other cases not subject to a protective order it may be released for use by all plaintiffs in M.D.L. No. 343. The Court ruled from the bench on December 1, 1978 that depositions taken in the Escher case are also to be made available to plaintiffs involved in this multi-district litigation.

The defendant, Upjohn, now asks this Court for a protective order to prevent the transmission of information obtained through discovery in the multi-district litigation to independent state cases brought against Upjohn alleging similar causes of action. According to the defendant such a practice would be improper, constituting a procedure outside the scope of multi-district discovery, as well as being an abuse of the policies of multi-district litigation. Upjohn contends that it is not the purpose of discovery to provide material for suits other than the current consolidated ones. The defendant also raises the question of whether plaintiffs may sell the materials, if permitted to share discovery with nonmulti-district cases. Finally Upjohn asserts that for the Court to permit this sharing of information would be to deprive Upjohn of the protection offered by more limited rules of discovery in some states.

The plaintiffs respond that under the rules set out in United States v. I. B. M., 67 F.R.D. 40 (S.D.N.Y.1975) and Reliance Insurance Co. v. Barron’s, 428 F.Supp. 200 (S.D.N.Y.1977), Upjohn is not entitled to prevent the dissemination of this information. They state that the information is not current; that it is maintained in several places and is filed with and obtainable through the FDA; and that disclosure will not place the company at a competitive disadvantage — except in that it may show Upjohn to have been a wrongdoer. The plaintiffs further contend that to enter a protective order of the sort Upjohn contemplates would be to place those persons allegedly injured by the drug Cleocin at a disadvantage for a number of reasons. One problem is that there are a limited number of experts available, and they would be reluctant to cooperate with repetitive discovery requests. The entry of a protective order presents additional problems in a case in which expert medical testimony is so important. It cannot be argued that in a typical case the hazardous nature of a substance is properly to be regarded as a trade secret. Indeed, it might well result in a [484]*484violation of medical ethics if a court were to require an expert acquainted with the hazards or potential hazards of a drug to conceal that knowledge from the public in general or particular patients. According to plaintiffs, duplicating discovery unnecessarily increases the total time and money required to prepare for trial. This is an especially important consideration where, as here, each individual’s potential recovery is likely to be small. Finally the plaintiffs contend that such a protective order would be a prior restraint on free speech.

In order to analyze properly the propriety of using information in one casé obtained through discovery in another, it is necessary to distinguish the rules applicable to the one, the role of the judge therein, and the interests involved from those that apply in the other case. The defendant does not suggest, and there is no reason to suspect, that the multi-district cases now pending before this Court were brought in bad faith merely as a means of obtaining information for use in other litigation. To have done so would constitute an abuse of the discovery process in the multi-district cases. See Johnson Foils, Inc. v. Huyck Corp., 61 F.R.D. 405, 410 (N.D.N.Y.1973); Beard v. New York Central Railroad Co., 20 F.R.D. 607, 610 (N.D.Ohio 1957); but cf. GAF Corp. v. Eastman Kodak Co., 415 F.Supp. 129, 131 (S.D.N.Y.1976); Crabtree v. Hayden, Stone, Inc., 43 F.R.D. 281 (S.D.N.Y. 1967). Therefore, to the extent that discovery has taken place and been disseminated among plaintiffs involved in this multidistrict action, nothing improper has taken place that would require entry of a protective order. Indeed it is the purpose of multi-district litigation to promote the sharing of discovery within the consolidated cases.

As far as its contemplated use in nonmul-ti-district litigation is involved, the Court must consider the sources and means which may properly be used in order to gather information for trial. It is evident that the discovery rules do not provide the only method of obtaining information. The Freedom of Information Act, for example, has come to be both a permissible and effective tool for trial preparation in some cases. Such an alternate avenue does not violate the Federal Rules of Civil Procedure and does advance certain of their policies, such as avoiding surprise at trial. F. T. C. v. Anderson, 442 F.Supp. 1118, 1124 (D.D.C. 1977). The Federal Rules themselves contemplate some flexibility in the discovery process, see F.R.Civ.P. 27(a)(4); 32(a), and nowhere expressly prohibit such a practice. See Standard Oil Co. v. Federal Energy Administration, 440 F.Supp. 328, 368 n. 103 (N.D.Ohio 1977). The two rules cited do not address the question of whether discovery may be shared between a'federal and state case on the same basis as between two federal cases. To distinguish between the two situations would be to make a distinc-tion on the basis of citizenship, a distinction which does not appear to have been intended. Where the parties have had similar interests and motives in the various cases, then it would appear that their rights have been adequately protected and there is no reason not to make the discovered materials available.

Nor can it be said that the plaintiffs in this complex litigation case have no interest in the use of multi-district discovery beyond these cases. Parties in other litigation may have knowledge of facts relevant to plaintiffs’ claims. Plaintiffs should be in a position to exchange information with other litigants with similar claims in order to develop their cases more fully.

Furthermore, it is inappropriate for this Court to limit the means by which litigants in cases not before it may obtain information which is not otherwise under a protective order. If Upjohn requires protection in other forums, then it should apply to the courts before which those cases are pending. F. T. C. v. Anderson, 442 F.Supp. 1118, 1124 (D.D.C.1977); Uinta Oil Refining Co. v. Continental Oil Co., 36 F.R.D. 176, 182 (D.Utah 1964).

The defendant has expressed its concern that the sale of this information may be accomplished by wholesale advertising and unethical practices such as barratry. The [485]*485Court sees nothing improper in plaintiffs involved in independent state cases who use the discovery material reimbursing the multi-district plaintiffs’ out-of-pocket costs. To do so would be in accord with the policies of the Federal Rules of Civil Procedure, which seek to secure the just, speedy, and inexpensive resolution of every action.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pincheira v. Allstate Insurance
2008 NMSC 049 (New Mexico Supreme Court, 2008)
Rivers v. Walt Disney Co.
980 F. Supp. 1358 (C.D. California, 1997)
Wauchop v. Domino's Pizza, Inc.
138 F.R.D. 539 (N.D. Indiana, 1991)
In re Wirebound Boxes Antitrust Litigation
128 F.R.D. 262 (D. Minnesota, 1989)
Danner v. Himmelfarb
858 F.2d 515 (Ninth Circuit, 1988)
Danner v. Himmelbarf
858 F.2d 515 (Ninth Circuit, 1988)
Whelan v. Merrell-Dow Pharmaceuticals, Inc.
117 F.R.D. 299 (District of Columbia, 1987)
Cipollone v. Liggett Group Inc.
106 F.R.D. 573 (D. New Jersey, 1985)
Johnson v. Richardson-Merrell, Inc.
582 F. Supp. 890 (Judicial Panel on Multidistrict Litigation, 1984)
Farnum v. G.D. Searle & Co.
339 N.W.2d 384 (Supreme Court of Iowa, 1983)
Bishop v. Firestone Tire & Rubber Co.
579 F. Supp. 397 (N.D. Indiana, 1983)
Koster v. Chase Manhattan Bank
93 F.R.D. 471 (S.D. New York, 1982)
Hoyt Construction Co. v. Alside, Inc.
538 F. Supp. 45 (D. Minnesota, 1982)
In Re Exterior Siding and Aluminum Coil Litigation
538 F. Supp. 45 (D. Minnesota, 1982)
Waelde v. Merck
94 F.R.D. 27 (E.D. Michigan, 1981)

Cite This Page — Counsel Stack

Bluebook (online)
81 F.R.D. 482, 27 Fed. R. Serv. 2d 389, 1979 U.S. Dist. LEXIS 14991, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-upjohn-co-antibiotic-cleocin-products-liability-litigation-mied-1979.